美國Kendle International Inc.  www.kendle.com
Kendle International Inc. (Nasdaq: KNDL) 是全球領(lǐng)先的臨床研究機構(gòu)，為全球生物制藥行業(yè)提供全面的初期到后期臨床開發(fā)服務(wù)。該公司所注重的創(chuàng)新型解決方案能夠為客戶縮短循環(huán)周期并加快增強生命的藥物推向市場，讓全球患者受益。作為發(fā)展最快的全球性 I-IV 期服務(wù)供應(yīng)商之一，該公司提供覆蓋99個國家和地區(qū)的業(yè)務(wù)經(jīng)驗，還有業(yè)界領(lǐng)先的患者招募途徑和保留能力以及廣泛的治療專長，可以解決其客戶面臨的臨床開發(fā)難題。
Kendle 被《財富》(FORTUNE) 雜志評為2008年美國發(fā)展最快的百強公司之一。該公司還在美國調(diào)查點的 CenterWatch 2007 調(diào)查中被列為“Top CRO to Work With”（最佳共事臨床研究機構(gòu)），在歐洲調(diào)查點的2008年調(diào)查中被列為“Top CROs in Europe”（歐洲最佳臨床研究機構(gòu)）之一。

Kendle is a leading global clinical research organization providing the full range of early– to late–stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide.
As one of the fastest-growing global providers of Phase I-IV services we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges. Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008 and was named "Top CRO to Work With" in the CenterWatch 2007 biannual survey of U.S. investigative sites.
For nearly three decades, Kendle has served customers, both large and small, and with a diversity of compounds, which means that our expertise spans every major therapeutic area. We have focused our therapeutic offerings on market needs and are already aligned with the top areas expected to represent more than 70 percent of worldwide drug sales through 2013: oncology/hematology, antibiotics/antivirals, cardiology, arthritis/inflammation, CNS, respiratory and diabetes/metabolism.1
Our vision
To be the best-in-class provider of clinical development services to the biopharmaceutical industry through broad therapeutic and geographic expertise.
Our corporate imperatives
Drive growth and profitability 
Focus on our customer and build our brand 
Maximize quality and increase capability 
Develop talent and reward performance